Aneurysmatic bone cyst is a hypervascularized, benign lesion locally destructive by its progressive growth with greater incidence in the second decade of life. It lodges preferably in the long bones and vertebrae. The clinical picture varies from pain to local edema and even neurological symptoms when in vertebral location. Three cases of vertebral aneurysmatic bone cyst occurring in childhood and all with neurologic deficit symptoms are described. Computerized tomography and/or magnetic resonance imaging confirmed the diagnosis. Patients underwent surgery to remove the tumor. In one of the cases, pre-operative selective arterial embolization of the lesion was performed. The three patients progressed satisfactorily with neurological improvement, which demonstrated the efficiency of the microsurgical technique for the resection of the spinal tumor. The evolution of the cases and the current treatment are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/s0004-282x2005000600030 | DOI Listing |
EFORT Open Rev
May 2024
Department of Orthopedics and Orthopedic Oncology, University of Padova, Padova, Italy.
The best treatment of unicameral bone cyst and aneurismatic bone cyst (ABC) is debated in the literature. For simple bone cysts, multiple treatments were proposed from observation only to open curettage. The historical treatment with intraosseous injection of methylprednisolone acetate into the bone cysts nowadays is reduced due to the morbidity of multiple injections and the risk of multiple pathologic fractures until the healing.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
May 2023
Cooperative Osteosarcoma Study Group, Pediatrics 5 (Oncology, Hematology, Immunology), Center for Pediatric, Adolescent and Women's Medicine, Stuttgart Cancer Center, Klinikum Stuttgart - Olgahospital, Kriegsbergstr. 62, 70174, Stuttgart, Germany.
Purpose: The course of osteosarcoma patients primarily treated as such has been well described. Little, however, is known about patients who were primarily treated assuming a different tumor diagnosis.
Methods: The database of the Cooperative Osteosarcoma Study Group COSS was searched (4.
World J Pediatr
October 2020
Department of Pediatric Endocrinology, Dr. v. Haunersches Children's Hospital, Ludwig-Maximilian-University of Munich, Lindwurmstr. 4, 80337, Munich, Germany.
Background: Pharmacologic options for treatment of osteolytic diseases especially in children are limited. Although not licensed for use, denosumab, a fully humanized antibody to RANKL, is used in children with good effects. Among others, one possible indication are giant cell tumors and aneurysmatic bone cysts.
View Article and Find Full Text PDFBreast J
July 2020
Servicio de Patología, Hospital de Dénia, Denia, Spain.
Acta Chir Orthop Traumatol Cech
January 2019
I. ortopedická klinika Fakultní nemocnice U sv. Anny v Brně, Lékařská fakulta Masarykovy univerzity Brno.
PURPOSE OF THE STUDY There are several treatment options for bone tumors at diaphyseal/metadiaphyseal sites of long bones (with joint preservation) including massive intercalary allografts, autografts (vascularized or non-vascularized fibular autograft, devitalised tumor bearing bone), endoprosthetic replacement (intercalary spacer), cementoplasty with ostheosynthesis and distraction osteogenesis. Reconstruction using massive intercalary bone allografts is for us the method of choice in case of curable primary bone tumors at the diaphyseal/metadiaphyseal region. The purpose of this study is to evaluate our results and complications.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!